Welcoming Message

On behalf of The Oman Pathology Society (OPS), It is my great pleasure as a chairperson of the Organizing Committee to welcome you to Muscat, Sultanate of Oman to attend the annual meeting of IAP Arab- division which will be held in Grand Hyatt Muscat Hotel, Muscat from 15th-18thNovember 2017.  I am sure this meeting is going to be beneficial for all participants in which medical knowledge and experience will be shared in the field of Histopathology and cytology which will be delivered by pioneer and expert speakers from different regions of the world including USA, Europe, Middle East and Asia to address the most recent advances in diagnostic and molecular pathology.

There is an excellent scientific program prepared by the organizing committee which includes eight sessions of breast, head and neck, lymph node, endocrine, soft tissue, urologic, gastrointestinal pathology and gynecologic cytology.  In addition the first day will be a workshop covering gynecologic surgical pathology.  This meeting is the first of its kind to be held in Muscat and it is a great opportunity to all of you to discover the beauty of our country.  An attractive social program will be conducted by the organizing committee to make your stay an enjoyable one.

I look forward to seeing each of you in Muscat and sincerely hope that you will join us to make this event a grand success.

 

Sincerely yours,

The Chairperson of the Organizing Committee of the 29th IAP-Arab Division Conference and Workshop.

Dr. Ibrahim Al Haddabi

Organizing Committees:

 

  • Organizing Committee ( Dr.Ibrahim Al-Haddabi, Chairperson).
  • Scientific Committee ( Dr. Hunaina Al-Kindi, Chairperson).
  • Social/Public Relations Committee ( Dr. Masoud Al-Kindi, Chairperson).
  • Financial/Marketing Committee (Dr. Nasser Al-Rahbi, Chairperson).
  • Registration Committee ( Dr. Maimuna Al-Saadi, Chairperson).

Welcome to the First Oman Pathology Society Conference along with the honor to organize the 29th Conference of International Academy of Pathology (IAP)- Arab Division here in Muscat, the capital of the Sultanate of Oman.

29th Conference of International Academy of Pathology (IAP) – Arab Divison

1st Oman Pathology Society Conference

 The schedule of the program:

Can be downloaded as pdf file through: Click here to download schedule

—————

Pre-Conference Workshop: Wednesday, 15th November 2017

8:30-15:45: Gynecologic Pathology Workshop
Faculty: Dr. Rouba Ali-Fehmi, Dr. Asma Faruqi and Dr Fadi Karim

14:00 – 16:00: IAP- AD Council Meeting
19:00 – 19:30: Opening ceremony
19:30 – 20:00: Kamal Ishak Lecture, Prof. Ray McMahon
20:00 – 23:00: Welcome reception

Day 1: Thursday, 16th November 2017


 

Day 2: Friday, 17th November 2017


 

Day 3: Saturday, 18 November 2017

Speakers

The honor to invite International Guest Speakers from different countries.

  • Prof. Kristin Henry
    Prof. Kristin Henry

    Prof/ Dr. Med.  Kristin Henry, MB.BS. FRCP. FRCPath. 

    Professor Emeritus at Imperial College London, Charing Cross Hospital Campus, London W6 8RF. IAP Past President. 

    Dr. Henry’s main fields of interest and research lie in:

    • Tumor pathology – all aspects – especially the pathogenesis and prognosis of 
    1. Haematopathological neoplasias (thymus, BM, lymph nodes, other extranodal   tissues including spleen), virus associated tumors, paraneoplastic syndromes, autoimmunity.  
    2. Melanoma; 
    • Post graduate education. 

                  Her work and research in all these areas are reflected in her numerous publications and major texts (250+), Grant Awards and her active participation in International and National Meetings as invited Speaker at Scientific Meetings, National as well as International and coordinator in countries World-wide. 

    Her contribution to pathology have led to many awards –viz, the Cunningham Medal for her contribution to Histopathology, BDIAP President’s Medal for her contribution to International Pathology Education and the IAP Gold Medal in 2012 for her ‘Outstanding Contribution to International Pathology Education and Research’. In 2011, she was honored by the BDIAP with the award of a ‘Named’ Lecture-the ‘Kristin Henry Lecture’ 

    She has held numerous positions on National and International Committees and Organizations in. Pathology. These have included the British National Lymphoma Investigation (BNLI) representative in the National Cancer Institute (NCI) retrospective study of Non-Hodgkin’s Lymphomas and Member of the Kettering Prize Award Committee of the General Motors Cancer Research Foundation. 

    Dr. Henry has made major contributions to learned societies as follows – 

    She served as a member of many tumor panels, eg. Cancer Research Council (CRC) Thymus Tumor Panel, the UK Melanoma Study Group, the European Bone Marrow Transplantation Society and the CRC British National Lymphoma Investigation (BNLI) Pathology Panel.

    She was the Co -Founder of the British Lymphoma Pathology Group (BLPG) and Founder Member of the European Bone Marrow Working Group (EBMWG). She initiated the formation of the Arab British School of Pathology- supported by the BDIAP and in collaboration with the ADIAP (now in its 15th year) and, with Martin Hansmann, is co-organizer of the Joint German and British IAP International Junior Academy Summer School – now in its 10th year. These Schools are especially designed to provide postgraduate education to young trainee pathologists. 

    Her Editorial activities are extensive and she was the Founder Editor of Current Histopathology.          

     As Emeritus Professor at Imperial College London her commitment to the advancement of global pathology education – especially to underserved Countries- continues as does her ongoing research.  

  • Prof. Wael Sakr
    Prof. Wael Sakr

    Dr. Wael Sakr is Professor and Chairman of the Department of Pathology & Laboratory Medicine at the Wayne State University School of Medicine and the Pathology Chief of Service for the Detroit Medical Center and the Karmanos Cancer Center in Detroit Michigan.

     

    He is internationally recognized for his expertise in the diagnosis, molecular/prognostic markers and natural history of genitourinary diseases, prostate cancer in particular. Dr. Sakr offered significant scientific contributions in the fields of pathology and pathobiology of urologic tumors with a focus on early neoplastic transformation. He has been an active participant in clinical trials and research plans aimed to characterize the morphologic and molecular processes associated with the progression potential of pre invasive neoplasia to invasive cancer. One aspect of these efforts has been a unique, two-cycle National Institute of Health funded RO1 grants designed to characterize the prevalence, morphologic and molecular features of early cancer and premalignant lesions of the prostate in a wide spectrum of age and ethnicities. This widely quoted study has influenced current thinking regarding the natural history and evolution of prostate cancer as well the design of screening and early detection trials, including the growing trend of managing patients with low grade, low stage prostate cancer by active surveillance.

     

    Dr. Sakr has been the principal and co- principal investigator on several research grants from the NIH and other funding agencies. He has chaired and organized numerous national and international conferences in the areas of early cancer detection and biomarkers and cancer prevention. Dr. Sakr has authored and co authored over 210 original publications and review papers and 15 book chapters. He also served on the World Health Organization and the American Joint Committee on Cancer panels and has contributed to a number of WHO and AJCC documents and books. Since the year 2000, Dr. Sakr has been consistently voted by his peers as one of the Best Doctors in America in his specialty. He has been the recipient of numerous national and international awards in his areas of expertise. 

     

    Dr. Sakr has been a steady and active participant and supporter of the Arab Division of the International Academy of Pathology for over 20 years and has served as the national president of the National Arab American Medical Association (NAAMA).

  • Prof. Abbas Agaimy
    Prof. Abbas Agaimy

    Abbas Agaimy, MD obtained his undergraduate medical degree from the Universities of Khartoum (Sudan) and Freiburg (Germany). He then worked at academic hospitals in Nuremberg, Amberg and Berlin and obtained his board certification in anatomic pathology from the Bavarian Medical Council, Munich. He then worked at Nuremberg Medical Center and the University Medical Center of Erlangen where he was appointed associate Professor of Pathology in 2008 and full professor of Pathology in 2012. Dr. Agaimy is currently professor of pathology and deputy director of the Institute of Pathology, university of Erlangen. Dr. Agaimy has authored and co-authored over 300 peer-reviewed scientific publications, in addition to several book chapters including the WHO books. His diagnostic expertise and research focus are the fields of soft tissue tumors, GI stromal tumors, GI pathology, head & neck pathology, renal tumor pathology, pathology of hereditary cancer syndromes and molecular pathology. Dr. Agaimy is a member of the educational committee of the German Division of the International Academy of Pathology (IAP), and is a regular tutor on the topics soft tissue pathology, head & neck pathology, renal tumor pathology, pathology of hereditary cancer syndromes and molecular pathology. He is serving on the Editorial Boards of several pathology journals including Advances in Anatomic Pathology, Virchows Archives, Head & Neck Pathology and others. He is a regular invited speaker at national and international meetings. Dr. Agaimy is a member of several academic societies including German Division of the IAP, German Society of Pathology (DGP), European Society of Pathology (ESP), United State and Canadian Academy of Pathology (USCAP), North American Society of Head and Neck Pathology, International Society of Immunohistochemistry, German Interdisciplinary Sarcoma Group (GISG) and others.

  • Dr. Asma Zaman Faruqi
    Dr. Asma Zaman Faruqi

    Dr. Asma Faruqi is a consultant histopathologist at the Barts Health NHS Trust in London and works in a subspecialised department reporting cytology and gynaecological pathology.  The Trust comprises five hospitals covering a large swathe of east London and is a tertiary referral centre for gynaecological cancer.

    Her interests include training and education and she is the Histopathology Training Programme Director for North East London and an examiner for the Royal College of Pathologists.  

    She has been a contributor to books on the pathology of the vulva and vagina and the pathology of the ovary, fallopian tube and peritoneum.  She is currently revising the vulval cancer datasets for the RCPath.

    For the last six years she has been the Honorary Secretary of the British Association of Gynaecological Pathologist (BAGP) and her term of office will end in June 2017. The BAGP has an international membership and organises meetings and courses that cover a wide range of gynaecological pathology.

  • Prof. Rouba
    Prof. Rouba

    Dr Rouba Ali-Fehmi is a Professor in the Departments of Pathology and Obstetrics and Gynecology Oncology at Wayne State University and Karmanos Cancer Institute.  She is the director of Surgical Pathology Fellowship at Wayne State University. She is very interested and dedicated towards teaching and research.  Since starting as a staff attending, she has mentored many gynecologic oncology and pathology fellows which ultimately led to more than 100 peer reviewed publications and presentations, both at national and international meetings.  In addition she received multiple honors such as Wayne State University College Teaching Award for Pathology and Obstetrics and Gynecology 2016 and the Recognition Award for Significant Contributions to the GYN/Oncology Fellows Teaching. Her area of interest is uterine high grade endometrioid and serous carcinoma and ovarian carcinoma. She has collaborated with nationally recognized institutions regarding her work on endometrioid and serous carcinoma.

    She is the president elect of NAAMA (National Arab American Medical Association) 2017 and a member of multiple national and international professional societies. She is also the WSU course director (contemporary issues in diagnostic pathology) since 2005 and the former president of the Michigan society of pathologist 20012-2014.

  • Dr. Mary Toner
    Dr. Mary Toner

    Dr. Mary Toner, MRCPath, FRCPath. Consultant/ Associate Professor in Histopathology with special interest in Oral Pathology, Departments of Histopathology and Department of Oral and Maxillofacial Surgery, Medicine and Pathology, School of Dental Science, Trinity College, Dublin. Appointed 1990.

    Lead in diagnostic oral and maxillofacial and head and neck pathology at St James’s and Dublin Dental University Hospital.

    National Speciality Director for Histopathology, Faculty of Pathology, Royal College of Physicians of Ireland.

    She has many peer-reviewed scientific publications, in addition to Contributor to WHO Classification of Head and Neck Tumours, January 2017, IARC.

  • Professor Raymond FT McMahon
    Professor Raymond FT McMahon

    MB BCh BAO BSc MD FRCPath FFPath (RCPI) FHEA

    The speaker graduated from the National University of Ireland in Galway (University College Galway) with MB BCh BAO in 1979. After HO and SHO in haematology jobs in Galway, he started a career in histopathology in Galway, acquiring honours BSc in pathology in 1982 and Part 1 MRCPath before moving to the University of Manchester in 1984. Having passed Part 2 MRCPath in histopathology by examination in 1986, he has successively been Lecturer, Senior Lecturer, Professor and Professor Emeritus at the University of Manchester; he is now consultant gastrointestinal pathologist in the NHS at Manchester Royal Infirmary. His research interests have been in urological, hepatic and gastrointestinal pathology with a particular interest in lectin histochemistry (the subject of his MD thesis in1992), inflammatory bowel disease, colorectal neoplasia including inherited syndromes, anal neoplasia including screening for high-risk populations, primary biliary cirrhosis and hepatitis C virus infection, publishing more than 85 peer reviewed papers. In diagnostic NHS pathology, he is lead clinical pathologist in colorectal cancer and bowel cancer screening for Central Manchester NHS Foundation Trust (CMFT). Educationally at undergraduate level, he has been chair of the Assessment Committee for the University of Manchester Medical School, the largest medical school in Europe with over 2000 students. He was until recently Hospital Dean for CMFT responsible for clinical training delivery to more than 420 students per year. At postgraduate level, he has been Training Programme Director (chair) of the North West Deanery Histopathology Training Programme (more than 40 trainees). He has been Chair of the Histopathology Examiners’ Panel and of the Steering Committee for Interpretive EQA for the Royal College of Pathologists. At a local level, he has been Secretary and Chairman and is currently President of the Manchester Medical Society, one of the oldest societies in UK medicine being over 175 years in existence. He is currently Treasurer and President-elect of the British Division of the International Academy of Pathology (BDIAP) and Secretary of the International Academy of Pathology, with more than 20000 members worldwide. He enjoys keeping personally fit by running, relaxes by reading and attending the theatre, watches Manchester United Football Club from the Stretford End and helps to look after his grandsons Conor and Dylan.

  • Professor Shahid Pervez
    Professor Shahid Pervez

    M.B.B.S, DCP (London), Ph.D (Histopath, London); FCPS (Histopath PK), FRCPath (UK)

    Professor Shahid Pervez & Senior Consultant Histopathologist at AKUH. His major diagnostic and research interests include ‘Haematopathology’, ‘Oral Pathology’ & ‘Predictive Pathology’. He has supervised several PhD & FCPS students and published extensively with over 200 research publications, several book chapters. He is also Editor of ‘Comprehensive Colour Atlas of Diagnostic & Predictive Histopathology’. He has served in various leadership positions and is currently the ‘Dean, Faculty of Histopathology, College of Physicians & Surgeons (CPSP), Pakistan’, & ‘Country Advisor by Royal College of Pathologists’, He played a pivotal role in establishing vibrant and active Pathology forums and is the Founder President of ‘IAP – Pakistan Division’, ‘Histopathology & Cytology Society of Pakistan (HCSP)’ & ‘SAARC Academy of Cytology & Histopathology (SACH)’. Dr Pervez is on editorial board of several prestigious journals and is listed as ‘Productive Scientist of Pakistan’ by ‘Pakistan Council of Science & Technology (PCST)’.

  • Dr. Fadi W. Abdul-Karim
    Dr. Fadi W. Abdul-Karim

    Dr. Fadi W. Abdul-Karim, M.D., MEd graduated from the American University of Beirut Lebanon in 1979.  He did his residency in anatomic pathology at Case Western Reserve University in Cleveland and a surgical pathology fellowship at M. D. Anderson Cancer Center in 1983-84.  He was on faculty at Case Western Reserve University/University Hospitals of Cleveland as professor of pathology and director of anatomic pathology and cytology until 2011.  In 2011 he returned to the American University of Beirut where he served as vice-chair of the department of Pathology and Laboratory Medicine and assistant dean for medical education.  Currently he is staff pathologist in the department of anatomic pathology at the Cleveland Clinic.  Dr. Abdul-Karim also has a master’s degree in medical education from Case and John Carroll University and serves as vice-chair for education of the Robert Tomsich -Pathology Laboratory Medicine Institute at the Cleveland Clinic. Dr Karim has authored more than 215 publications, and many book chapters and has been a speaker at many National and International Conferences.

  • Professor Naila Kayani
    Professor Naila Kayani

    Professor and Consultant Dr. Naila Kayani, Department of Pathology & Laboratory Medicine, Aga Khan University, Karachi, Pakistan.

    Prof. Kayani is a medical graduate of Fatima Jinnah Medical University, Lahore. Did her residency training in USA and is board certified in Anatomic and Clinical pathology. She is a fellow of College of American Pathologist and Royal College of Pathologist, UK. She has been chair and laboratory director of the department and clinical laboratories from 2010-2015 .She is currently the member of the faculty of histopathology at the College of Physicians and Surgeons and has served in the past as Dean of this faculty.  Her special areas of interest in clinical care are breast and gynecologic pathology and other areas of interest are postgraduate medical education and quality improvement processes. She has held close to 24 national and international workshops and given 50 invited lectures in the area of her interest .She has 145 indexed publications to her credit. In addition Councilor’, International Academy of Pathology (IAP)– Pakistan Division ,Fellow & Councilor, College of Pathologist, Pakistan-F03807A18,Founding Member and Vice President, Histopathology & Cytology Society of Pakistan (HCSP).Founding & Executive Member &Joint Secretary, SAARC Association of Cytology & Histopathology (SACH).

  • Dr. Elizabeth Montgomery
    Dr. Elizabeth Montgomery

    Dr. Elizabeth Montgomery holds the title of Professor of Pathology, Oncology, and Orthopedic Surgery and directs the Division of Gastrointestinal Pathology at Johns Hopkins Medical Institutions in Baltimore, USA.  She is the Editor in Chief for the 5th Series of Armed Forces Institute of Pathology/American Registry of Pathology fascicles.  She is an author of numerous articles and books concerning gastrointestinal and soft tissue pathology.

  • Dr. Ronald de Krijger
    Dr. Ronald de Krijger

    Dr. Ronald de Krijger did his Pathology training at Erasmus MC – University Medical Center in Rotterdam, The Netherlands from 1994 to 1999 and then became a staff member at the same institution. In 2010 he was appointed as Professor of Paediatric Pathology and in 2011 he became the Director of the Residency Programme.  In 2012 he left Erasmus MC and became a staff pathologist at Reiner de Graaf Hospital, Delft. Since 2015 he is also a staff pathologist at University Medical Center/Princess Maxima Center for paediatric oncology, Utrecht, The Netherlands. He has a strong interest in endocrine pathology and in paediatric oncology. He has published more than 200 peer-reviewed papers and was the promoter or co-promoter of 10 PhD students.

  • Dr. Tomas Slavik
    Dr. Tomas Slavik

    MBChB, MMed, FCPath(SA)

    Obtained his undergraduate medical and anatomical pathology speciality degrees from the University of Pretoria in South Africa.  He then worked at Duke University Medical Center, North Carolina, USA in 1996/7, spending much of this time on the gastrointestinal pathology service under the late Dr Marcia Gottfried.  Dr Slavik is currently a senior Partner Pathologist at Ampath Pathology Laboratories, and Extraordinary Lecturer in the Department of Anatomical Pathology at the University of Pretoria.  He has multiple publications in international peer-reviewed journals, including those in his subspeciality field of interest – GI pathology.  Dr Slavik is an ad hoc reviewer for The Journal of Gastroenterology, a co-author of a textbook chapter, on the Editorial Advisory Board of the American Registry of Pathology (ARP) for the 5th Series of ARP Fascicles and on the Editorial Board of the South African Journal of Gynaecologic Oncology. Dr Slavik has presented numerous invited lectures internationally, and is a member of various professional and academic organizations, including the College of American Pathologists (CAP), the European Network of Gastrointestinal Pathology (ENGIP), and both British and South African Divisions of the International Academy of Pathology (IAP).

  • Professor Emad Rakha
    Professor Emad Rakha

    Professor and Honorary Consultant Pathologist Department of Histopathology, The University of Nottingham and Nottingham University Hospitals NHS Trust. Dr Rakha has authored over 235 peer-reviewed scientific publications, in addition to several chapters in medical and pathology textbooks in the field of breast disease including the WHO book. He is member of the National Co-ordinating Committee for Breast Pathology (BIG18), UK PathSoc Educational Committee, The National Cancer Research Institute Breast CSG and the Translational Subgroup, International society of Breast Pathology Committee, Breast Cancer Now Tissue bank Access Committee, Nottingham Health Science Biobank Board and. Professor Rakha has been reporting breast referral cases in Nottingham since 2011 and he reports private breast cases referred to Source Biosciences.

Fees for registration:


* Limited number of seats for Pre-course Workshop (First come, first served).

** Residents must present evidence of residency status.

 

Payment is through bank transfer to:

Bank: Bank Muscat

Branch: Qurum

Account number: 0316005366510013

Swift code: BMUSOMRxxxx

And send the bank transfer to e-mail:  iap.ad.oman2017@gmail.com

(Please note that the payment is not refundable)

 

The registration includes:

  • Conference lectures.
  • Tea and coffee breaks.
  • Lunch during the conference days.
  • Accredited certificate of attendance.

 

Registration form:

    YesNo

    YesNo

    YesNo

    Abstract submission guidelines:

    • Registration to the conference is mandatory to enable delegates to present their abstract.
    • If the speaker fails to register and pay the delegate fees before the deadline, his/ her abstract will not be included in the abstract book.
    • Abstracts are to be submitted in English, should not exceed 300 words and be structured in the following specified subtitles: Objective, Methods, Results and Conclusion.
    • Case reports; as far as possible should be structured as specified above.
    • Changes in authorship, if any should be communicated to the Scientific Committee at the earliest.
    • All the abstracts will be scrutinized by the scientific committee and the decision regarding their acceptance will be communicated to the presenting author.

     

    Poster presentation guidelines:

    • The recommended poster size (standard measurement) is A0 size: 90cm (width) x 120cm (height). Orientation: Portrait. You are not required to use up the entire space.
    • Guidelines for font sizes: Title 96 points, Authors’ names 72 points (use family name and first name), Institution 36-48 points, Text minimum 20 points.
    • The poster content must be presented in such a way that delegates standing at a distance of one to two meters can clearly view the texts and illustrations.
    • Presenters are responsible for display and removal of their posters.
    • The Organizing Committee will not be responsible for any loss or damage to the posters during the display.

     

     

    Abstract Submission:

    (Deadline for abstract submission on 15th of October 2017)

      The venue of the conference:

      Grand Hyatt Muscat Hotel, Shatti Al Qurum, Muscat, Sultanate of Oman. 

      Website: https://muscat.grand.hyatt.com/en/hotel/home.html

      About Oman

      Officially the Sultanate of Oman (Arabic: سلطنة عُمان‎‎ Salṭanat ʻUmān), is an Arab country on the southeastern coast of the Arabian Peninsula. Holding a strategically important position at the mouth of the Persian Gulf, the country shares land borders with the United Arab Emirates to the northwest, Saudi Arabia to the west, and Yemen to the southwest, and shares marine borders with Iran and Pakistan to the north, and India to the east. The coast is formed by the Arabian Sea on the southeast and the Gulf of Oman on the northeast. The Madha and Musandam exclaves are surrounded by the UAE on their land borders, with the Strait of Hormuz (which it shares with Iran) and Gulf of Oman forming Musandam’s coastal boundaries.

      Muscat:

      Muscat (Arabic: مسقط‎‎, Masqaṭ pronounced [ˈmasqatˤ]) is the capital and largest metropolitan city of Oman. It is also the seat of government and largest city in the Governorate of Muscat. Since the ascension of Qaboos bin Said as Sultan of Oman in 1970, Muscat has experienced rapid infrastructural development that has led to the growth of a vibrant economy and a multi-ethnic society.

      Language: Arabic (main), English (widely spoken).

      Religion: Islam.

      Area: 309,500 km2 (119,500 sq mi).

      Population: 4,572,949 (2016 estimate).

      Country phone code: (+968)

      Time zone: GST (UTC+4)

      Currency: OMR (Omani Rial).

      Working days: Sunday to Thursday. Weekend: Friday and Saturday.

      Visa application: https://www.rop.gov.om/visa/english/onlineservices_visaapplication_main.aspx

      Tourism links: http://www.omantourism.gov.om

      Contact us through:

       

      E-mail: iap.ad.oman2017@gmail.com
      Histopathology Education Committee: (+968) 2418-1014